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Abstract
OBJECTIVE—To examine characteristics and causes of legal induced abortion–related deaths in 
the United States between 1998 and 2010.
METHODS—Abortion-related deaths were identified through the national Pregnancy Mortality 
Surveillance System with enhanced case-finding. We calculated the abortion mortality rate by 
race, maternal age, and gestational age and the distribution of causes of death by gestational age 
and procedure.
RESULTS—During the period from 1998–2010, of approximately 16.1 million abortion 
procedures, 108 women died, for a mortality rate of 0.7 deaths per 100,000 procedures overall, 0.4 
deaths for non-Hispanic white women, 0.5 deaths for Hispanic women, and 1.1 deaths for black 
women. The mortality rate increased with gestational age, from 0.3 to 6.7 deaths for procedures 
performed at 8 weeks or less and at 18 weeks or greater, respectively. A majority of abortion-
related deaths at 13 weeks of gestation or less were associated with anesthesia complications and 
infection, whereas a majority of abortion-related deaths at more than 13 weeks of gestation were 
associated with infection and hemorrhage. In 20 of the 108 cases, the abortion was performed as a 
result of a severe medical condition where continuation of the pregnancy threatened the woman’s 
life.
CONCLUSION—Deaths associated with legal induced abortion continue to be rare events—less 
than 1 per 100,000 procedures. Primary prevention of unintended pregnancy, including those in 
women with serious pre-existing medical conditions, and increased access to abortion services at 
early gestational ages may help to further decrease abortion-related mortality in the United States.
Over the past 35 years, approximately half of pregnancies in the United States were 
unintended. Of these, about 40% were terminated by induced abortion,1,2 with an estimated 
1.1 million legal induced abortions performed in the United States in 2011.3 Since its 
legalization in 1973, the mortality rate from legal induced abortion has remained very low, 
at about 1 abortion-related death per 100,000 abortion procedures (Fig. 1).4 Changes in the 
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population of women of reproductive age as well as changes in abortion techniques and 
methods, such as the approval in 2000 of mifepristone for early medical abortion, may 
potentially affect mortality from abortion.
The Division of Reproductive Health at the Centers for Disease Control and Prevention 
(CDC) has done national epidemiologic surveillance of mortality associated with legal 
induced abortion since 1972.5 All potential deaths from abortion receive in-depth 
investigation: abortion mortality rates are reported annually in the CDC’s Abortion 
Surveillance Reports,4 and more comprehensive analyses are published periodically in peer-
reviewed publications that cover the years 1972–1997.6–8 To provide the most recent, 
complete information on deaths related to legal induced abortion, this article summarizes 
key epidemiologic and clinical information on these deaths in the United States between 
1998 and 2010.
MATERIALS AND METHODS
The first source of potential cases of deaths related to induced abortion is the CDC 
Pregnancy Mortality Surveillance System. This system mainly relies on vital records (ie, 
death certificates and matching live birth or fetal death certificates, if available) received 
from all 50 states, Washington, DC, and New York City.9 During review of these 
pregnancy-associated deaths (ie, deaths during or within 1 year of pregnancy), CDC 
epidemiologists identify all deaths potentially associated with induced abortion. Additional 
methods used to identify other potential abortion-related deaths include media reports, such 
as computerized searches of Lexis Nexis, and reports by public health agencies, state-based 
maternal mortality review committees, professional organizations, health care providers, and 
individuals.
For all potential abortion-related deaths, medical records and autopsy reports are requested 
and an in-depth investigation conducted. Two clinically trained CDC epidemiologists 
separately review the data, reach consensus on the cause of death, abortion type (legal 
induced, illegal induced, spontaneous, or unknown), and gestational age. In cases with 
adequate medical documentation, they assess whether the woman had a severe medical 
condition where continuing the pregnancy threatened her life, such as pulmonary 
hypertension; severe or end-stage renal or hepatic disease; or major hematologic, 
autoimmune, or metabolic conditions, or whether the abortion was done in an attempt to 
save her life. Data then are abstracted using standardized case summary forms.
An abortion is defined as legal if it is performed by a licensed clinician and as illegal if 
performed by any other person.4 An abortion-related death is defined as a death resulting 
from a direct complication of an induced abortion, an indirect complication caused by a 
chain of events initiated by an abortion procedure, or the aggravation of a pre-existing 
condition by the physiologic or psychological effects of the abortion.4 All deaths determined 
to be causally related to induced abortion are classified as abortion-related regardless of the 
time between the abortion and death.4 In addition, any pregnancy-related death (ie, deaths 
causally related to pregnancy) in which the pregnancy outcome is induced abortion is 
considered an abortion-related death regardless of the causal relation between the abortion 
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procedure itself and death.4 Finally, if the death occurs from an unrecognized ectopic 
pregnancy after a legal induced abortion for presumed intrauterine pregnancy, the case is 
considered abortion-related.
The type of abortion procedure was categorized as: 1) no procedure if Laminaria were 
placed or anesthesia was performed but the planned abortion procedure never occurred; 2) 
medical procedure if medication(s), but no surgical instruments, were used to induce an 
abortion; at 8 weeks of gestation or less, this procedure typically entailed administration of 
mifepristone followed by misoprostol; at more than 8 weeks of gestation, it typically 
entailed the administration of vaginal prostaglandins; 3) suction curettage (formerly dilation 
and curettage) for surgical abortion at 13 weeks of gestation or less; 4) dilation and 
evacuation for surgical abortion at more than 13 weeks of gestation; 5) other procedure (ie, 
intrauterine instillation other surgical procedure); and 6) unknown procedure. Causes of 
death were categorized per the Pregnancy Mortality Surveillance System as hemorrhage, 
infection, embolism (thrombotic and amniotic), anesthesia complications, cardiovascular 
conditions, and other noncardiovascular medical conditions, such as pulmonary, collagen 
vascular, renal, and hematologic conditions.10 Other variables were categorized as follows: 
gestational age at the time of the procedure (8 or less, 9–13, 14–17, 18 or more completed 
weeks of gestation), age (19 years or younger, 20–24, 25–29, 30–34, 35 years or older), race 
(white, black, other); Hispanic origin (yes, no, unknown), nativity (U.S.- or foreign-born), 
gravidity (1, 2, 3 or more, unknown), number of previous live births (0, 1, 2, 3 or more, 
unknown), education (11th grade or less, 12th grade, more than 12th grade, unknown), and 
marital status (never married, married or cohabiting, divorced or widowed, unknown).
Data for the denominator (ie, annual numbers of legal induced abortions in the United 
States) were from the Guttmacher Institute (Table 1)3; we applied the gestational age 
distribution from the CDC’s Abortion Surveillance System to obtain the number of abortion 
procedures by gestational age category.4 Information on gestational age at the time of 
procedure was missing for six cases. Assignment of gestational age to these cases is 
described in Scenario 5 in Table 2. To estimate the distribution of abortion procedures by 
race–Hispanic ethnicity and maternal age, we used data from the 2000 and 2008 Guttmacher 
Institute Abortion Patient Surveys.11,12 The distribution of abortion procedures for these two 
variables in the two surveys was essentially identical, and we used the mean distribution to 
calculate the number of abortion procedures by race–ethnicity and maternal age. For other 
variables of potential interest, there was not sufficient information either for the cases or the 
number of procedures to allow calculation of mortality rates. For these variables, we 
tabulated the distribution of the characteristics among the women with abortion-related 
deaths.
The abortion mortality rate, defined as the number of abortion-related deaths per 100,000 
abortion procedures, was calculated for the study period 1998–2010 by race and Hispanic 
ethnicity, maternal age, and gestational age category. We tabulated the distribution of causes 
of death by gestational age and type of abortion procedure. All analyses were performed in 
Stata 12. Surveillance and research activities summarized in this report were deemed exempt 
from review by the CDC’s institutional review board.
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RESULTS
Between 1998 and 2010, among approximately 16.1 million abortion procedures in the 
United States, there were 108 legal induced abortion–related deaths, yielding an abortion 
mortality rate of 0.7 deaths per 100,000 legal induced abortion procedures; the mortality rate 
was 0.4 for non-Hispanic white women, 0.5 for Hispanic women, 1.1 for black women, and 
0.7 for women of other races. The mortality rates by maternal age were 0.04, 0.6, 0.6, 1.1, 
and 0.9 for women 19 years and younger, 20–24, 25–29, 30–34 and 35 years or older, 
respectively. The annual number of deaths ranged between four deaths in 1999 and 12 
deaths in 2008, for an annual mortality rate between 0.3 and 1.0 per 100,000 procedures.4 Of 
the 108 abortion-related deaths, 28 followed procedures performed at 8 weeks of gestation 
or less, 23 between 9 and 13 weeks, 21 between 14 and 17 weeks, and 36 at 18 weeks or 
greater (Table 3). Abortion mortality rates increased with gestational age, from 0.3 deaths 
per 100,000 procedures performed at 8 weeks of gestation or less to 6.7 deaths per 100,000 
procedures performed at 18 weeks of gestation or greater (Fig. 2). The distribution of deaths 
from abortion-related causes by key sociodemographic characteristics is shown in Table 3.
Of the 48 women who died after undergoing abortion at 13 weeks of gestation or less, 28 
had undergone surgical abortion and 12 had undergone a medical abortion procedure (Table 
4). The most common cause of death after a surgical abortion at 13 weeks of gestation or 
less was anesthesia complications (13 deaths); after medical abortion at 13 weeks of 
gestation or less, the most common cause of death was infection (9 deaths). Of the 54 
women who died after undergoing abortion at more than 13 weeks, 39 had undergone 
surgical abortion and eight had undergone a medical abortion procedure. The most common 
causes of death after a second-trimester surgical abortion were hemorrhage (16 deaths) and 
infection (12 deaths).
Nine of the 20 deaths after medical abortion were caused by infection with Clostridium 
species; seven of these women had confirmed infection with Clostridium sordellii after 
using mifepristone-misoprostol at 4–7 weeks of gestation, and two had confirmed infection 
with Clostridium perfringens, one after using mifepristone with misoprostol at 8 weeks of 
gestation and one after use of Laminaria and misoprostol at 19 weeks of gestation. Among 
the deaths attributable to anesthesia, the methods used varied from local only to combined 
local and intramuscular–intravenous sedation to general anesthesia. Overall, 20 abortion-
related deaths (19%) occurred among women with severe medical conditions where 
continuing the pregnancy threatened the life of the woman. The vast majority of these 
conditions existed before the pregnancy.
DISCUSSION
In the United States during the period from 1998–2010, an average of eight abortion-related 
deaths were identified each year, for an abortion mortality rate of 0.7 per 100,000 legal 
induced abortion procedures, the rate being 0.4 for non-Hispanic white women, 0.5 for 
Hispanic women, and 1.1 for black women. The mortality rate increased with increasing 
age, from 0.4 for women 19 years and younger to 1.1 for women 30–34 and 0.9 for women 
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35 years and older. The abortion mortality rate has been stable for the past 3 decades (Fig. 1) 
and is in line with corresponding rates in other developed countries.13
The most frequent causes of death were infection and anesthesia complications after medical 
and surgical abortions, respectively, at 13 weeks of gestation or less, and hemorrhage and 
infection after abortions at more than 13 weeks. Gestational age at the time of the abortion 
remains the strongest risk factor for abortion-related mortality.8 Abortion-related deaths are 
clinically and statistically rare events, and the risk of death after an abortion at 8 weeks of 
gestation or less is 0.3 per 100,000 or 3 per million procedures. However, even at 18 weeks 
or later, the risk of mortality was low, 6.7 deaths per 100,000 procedures. Ways to facilitate 
access to abortion services at lower-risk, early gestational ages warrant further examination.
Black women have a risk of abortion-related death that is three times greater than that for 
white women. This is similar to the black:white risk ratio for all pregnancy outcomes of 
3.2.9,14 The reason for this remains unclear; abortion surveillance data from 29 states (which 
exclude California, Florida, Illinois, and Mississippi) suggest that black women, compared 
with non-Hispanic white women, are only slightly less likely to obtain abortions in the first 
trimester—90% compared with 93%.4
This is the first analysis of abortion-related mortality surveillance data after U.S. Food and 
Drug Administration (FDA) approval in 2000 of mifepristone for early medical abortion. 
Mifepristone has become an integral part of abortion provision in the United States and 
contributed to the trend toward very early abortions.15,16 Of note are eight deaths due to 
Clostridium species infection after early medical abortions using mifepristone with 
misoprostol. Clinical details on these deaths have been reported previously after in-depth 
investigations by the FDA and CDC.17–20
Additionally, this analysis includes information on the number of women whose abortions 
were done in an attempt to save their lives, comprising almost 20% of all the abortion deaths 
in this time period. All but one of these 20 deaths were due to serious pre-existing medical 
conditions exacerbated by pregnancy, such as pulmonary hypertension and end-stage renal 
disease. Counseling such women about the very real risks of pregnancy and the provision of 
the most effective methods of contraception should be part of their ongoing care.
This study is not without limitations. Reporting of pregnancy-associated deaths by states to 
the Pregnancy Mortality Surveillance System may be incomplete. However, the CDC uses 
multiple other methods to identify such deaths, and every report of a potential abortion-
related death is followed up and investigated. Moreover, ascertainment of deaths after 
abortions with mifepristone benefits from the mandatory reporting of possible medication-
related serious adverse events to Danco Laboratories, the single distributor of mifepristone 
in the United States, and to the FDA.21 Also, important clinical information (eg, gestational 
age, specific abortion procedure, or cause of death) was not available for a small proportion 
of abortion-related deaths.
Legal induced abortion remains an extremely safe procedure, with a mortality rate of 0.7 per 
100,000 procedures. The published mortality rate for pregnancies ending in a live birth is 8.8 
deaths per 100,000 live births.22 Improved access to abortion services at lower-risk, early 
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gestational ages will lower abortion mortality even more. Regardless, primary prevention of 
unintended pregnancy is optimal, especially for women with the most serious medical 
conditions. As in all areas of medicine, continuous quality improvement in clinical practices 
should be encouraged and monitoring of trends in procedures and outcomes continued.
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Fig. 1. 
Legal induced abortion mortality, number of deaths, and abortion mortality rates, United 
States, 1973–2010.
Zane. Abortion Mortality in the United States. Obstet Gynecol 2015.
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Fig. 2. 
Distribution of legal induced abortion deaths and abortion mortality rates by gestational age, 
United States, 1998–2010.
Zane. Abortion Mortality in the United States. Obstet Gynecol 2015.
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Table 3
Characteristics and Gestational Ages of Women With Abortion-Related Deaths: Pregnancy Mortality 
Surveillance System, United States, 1998–2010 (N=108)
Sociodemographic Characteristics Total
Age (y)
  19 or younger 13 (12)
  20–24 30 (28)
  25–29 25 (23)
  30–34 23 (21)
  35 or older 17 (16)
Race
  White 43 (40)
  Black 55 (51)
  Other 10 (9)
Hispanic origin
  Hispanic 20 (19)
  Non-Hispanic 84 (78)
  Unknown 4 (4)
Nativity
  US-born 82 (76)
  Foreign-born 26 (24)
Gravidity
  1 9 (8)
  2 17 (16)
  3 or more 47 (44)
  Unknown 35 (32)
No. of previous live births
  0 8 (7)
  1 21 (19)
  2 16 (15)
  3 or more 20 (19)
  Unknown 43 (40)
Education
  11th grade or less 23 (21)
  12th grade 42 (39)
  More than 12th grade 34 (32)
  Unknown 9 (8)
Marital status
  Never married 69 (64)
  Married or cohabiting 28 (26)
  Divorced or widowed 10 (9)
  Unknown 1 (1)
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Sociodemographic Characteristics Total
Gestational age (wk)
  8 or less 28 (26)
  9–13 23 (21)
  14–17 21 (19)
  18 or greater 36 (33)
Data are n (%).
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Table 4
Distribution of Causes of Death by Gestational Age and Type of Abortion Procedure: Pregnancy Mortality 
Surveillance System, United States, 1998–2010
Gestational
Age and Procedure
Cause of Death
n Hemorrhage Infection
13 wk of gestation or less 48 5 19
  No procedure* 1 0 0
  Medical procedure† 12 2 9
  Suction curettage 28 2 6
  Unknown procedure 7 1 4
More than 13 wk of gestation 54 17 17
  No procedure* 4 0 3
  Medical procedure† 8 1 1
  Dilation and evacuation 39 16 12
  Other procedure‡ 2 0 0
  Unknown procedure 1 0 1
Unknown gestational age 6 0 1
Total, all gestational ages and all procedures 108 22 37
Cause of Death
Embolism Anesthesia Complications Cardiovascular Diseases Medical, Noncardiovascular Conditions Unknown
5 14 1 3 1
0 1 0 0 0
0 0 1 0 0
3 13 0 3 1
2 0 0 0 0
5 7 3 4 1
0 1 0 0 0
2 0 2 2 0
2 6 1 1 1
1 0 0 1 0
0 0 0 0 0
2 1 1 1 0
12 22 5 8 2
Data are n.
*No procedure: Laminaria placed or anesthesia administered but planned abortion procedure never occurred.
†
Medical procedure: administration of medication(s), typically mifepristone followed by misoprostol at 8 weeks of gestation or less and vaginal 
prostaglandins at more than 8 weeks of gestation.
‡Other procedures: hysterotomy and intrauterine instillation.
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